S M Assad
@assad_sm
Followers
253
Following
1K
Media
4
Statuses
65
MD(General Medicine)@GMCNagpur|DM(Nephrology) @OffCMCVellore|@GlomCon Fellow 2025-2026|SoMe Team @CMCNephrology
Vellore, India
Joined April 2019
Original Article: Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (PISCES trial) https://t.co/m4W5oUljyX Editorial: Fish Oil for Patients Receiving Hemodialysis — Red Herring or Great Catch? https://t.co/MRvzOdneNP
@ASNKidney | #KidneyWk
1
78
310
📢 RCC 2026 | 9th Annual Renal Symposium & 18th Renal Clinical Conference 📍 Christian Medical College, Vellore 🗓️ July 24–25, 2026 🎯Acute Kidney Injury – The Next Generation Day 1️⃣: Dive deep into AKI with the latest research, expert insights, and hands-on learning.
0
6
11
Spoke about “the use of artificial intelligence in literature review” as part of the @WomenNeph_india clinical research training program. Wonderful engagement from participants. Thanks to Dr Xavier for leading this program. @ISNkidneycare @AnandhUrmila
0
3
13
Thrilled to attend “From Idea to Impact:Clinical Research Training Fellowship” — a masterclass for research by @WomenNeph_india . Honoured to hear Dr Denis Xavier share practical research wisdom. Great learning in Hyderabad… and yes, the biryani was a serious bonus 🍛!!
0
3
9
🚀Kick starting @WomenNeph_india Clinical research training program with our lead faculty Dr Denis Xavier! Amazing enthusiasm from the participants! Hope to keep the momentum going🚴🚴♀️🚴🏻♂️@ISNkidneycare
1
2
9
Attending the inaugural @WomenNeph_india Clinical Research Training Program at Hyderabad ! 📚 Can research be FUN? An absolute YESS!! ✅ Fantastic hospitality, insightful sessions, and a surprising amount of fun along the way! 🙌 #nephtwitter #ISNeducation
0
4
11
#Anti-podocin Enzyme-Linked Immunosorbent Assay Guides Immunotherapy in #Steroid-Resistant #Nephrotic Syndrome https://t.co/lUx9tcUkHx
#KIRNephrologyRounds
1
5
16
50 years of wisdom concentrated in 40 minute - Dr KS Chugh Oration by Prof Ramesh Khanna - Building Bridges - From Peritoneum to People.
1
5
12
⏩ Next #NephJC is on IgA nephropathy @goKDIGO guideline 🎨 Nice visual summary by @roxnonna23
https://t.co/gMuklrTlz7
0
32
63
The 2025 @goKDIGO IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #NephJC ✍️Summary by @AgavriloaeiB and Janany Sabescumar https://t.co/mJUc455tvl
nephjc.com
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
1
25
38
One of the main goals of our review article in @NEJM on MGUS was to provide clear clarifications on the concept of “monoclonal gammopathy of clinical significance” (MGCS). It’s all very confusing in the literature and can cause problems for patients if we are not totally clear of
nejm.org
MGUS is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. Diagnosis warrants follow-up, but treatment is not required unless progression i...
6
77
251
Hello, world! 🌏 This is the official page of the Department of Nephrology, Christian Medical College, Vellore. Pioneering India's first hemodialysis in 1961 and the first successful kidney transplant in 1971, CMC Nephrology has grown into a leading comprehensive center for
0
9
23
Join us TOMORROW 10/16/25 at 1 PM CST for a LIVE @Rush_Nephrology renal biopsy conference. This was a tough case with some VERY important surprises. #RushRenalRules
0
7
12
Check at the VA for our discussion of protein diet strategies by @msocoMD . Is restricting protein in CKD and pushing protein in ESRD #TWDFNR? https://t.co/PE9Jjg233Y
nephjc.com
We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?
0
8
13
Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘. Join the discussion 9/30/25 at 9 pm EST on #Bluesky #NephTwitter #MedTwitter
https://t.co/jCJLWG9Tju
nephjc.com
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
0
10
18
This is an incredibly proud moment for us all @CCHRCCancerCare @DrRRaviKannan
@OffCMCVellore @MathewsVikram
0
2
19
Join us tomorrow 9pm EST only on #BlueSky We will be discussing the use of spironolactone in patients on dialysis to prevent cardiovascular 🫀outcomes and heart failure hospitalizations 🏥. Invite your friends! #NephJC #Nephtwitter
https://t.co/LYvJ1IS5Hx
nephjc.com
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
0
8
25
1/ 35 year old software engineer dies at age 35; CT surgeon age 39 dies of massive coronary event. News of this kind seems more frequent now than ever before. Why? Is it just more reporting, more population or a "modern life style"?
1
2
4